Univariate and multivariate analysis for DFS
. | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P . | HR . | 95% CI . | P . |
CR1 duration* | .93 | .88-.97 | .002 | .92 | .86-.98 | .01 |
GO | .45 | .23-.84 | .01 | .40 | .17-.90 | .03 |
AlloSCT | .58 | .34-.99 | .05 | .75 | .37-1.50 | .41 |
Age*† | 1.19 | .99-1.44 | .07 | 1.40 | 1.03-1.90 | .03 |
CBFB vs CBFA | 1.15 | .66-1.99 | .65 | .48 | .23-1.01 | .05 |
Primary trial | ||||||
ALFA-9801 as baseline | ||||||
ALFA-9802 | .69 | .28-1.67 | .42 | .42 | .09-1.99 | .27 |
LAM-2001 | 1.11 | .54-2.28 | .77 | 1.90 | .65-5.60 | .24 |
CBF-2006 | .48 | .22-1.08 | .08 | .73 | .17-3.09 | .67 |
. | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P . | HR . | 95% CI . | P . |
CR1 duration* | .93 | .88-.97 | .002 | .92 | .86-.98 | .01 |
GO | .45 | .23-.84 | .01 | .40 | .17-.90 | .03 |
AlloSCT | .58 | .34-.99 | .05 | .75 | .37-1.50 | .41 |
Age*† | 1.19 | .99-1.44 | .07 | 1.40 | 1.03-1.90 | .03 |
CBFB vs CBFA | 1.15 | .66-1.99 | .65 | .48 | .23-1.01 | .05 |
Primary trial | ||||||
ALFA-9801 as baseline | ||||||
ALFA-9802 | .69 | .28-1.67 | .42 | .42 | .09-1.99 | .27 |
LAM-2001 | 1.11 | .54-2.28 | .77 | 1.90 | .65-5.60 | .24 |
CBF-2006 | .48 | .22-1.08 | .08 | .73 | .17-3.09 | .67 |